Atlas Trials

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Clinical trial NCT00640640 · UNKNOWN

Trial details

NCT number
NCT00640640
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neovascular Age Related Macular Degeneration
Start date
2007-08-01
Primary completion
2008-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.